Correlation Between Lipocine and Summit Therapeutics

Can any of the company-specific risk be diversified away by investing in both Lipocine and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lipocine and Summit Therapeutics PLC, you can compare the effects of market volatilities on Lipocine and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Summit Therapeutics.

Diversification Opportunities for Lipocine and Summit Therapeutics

0.02

Correlation Coefficient

Lipocine  Summit Therapeutics

Significant diversification

The 3 months correlation between Lipocine and Summit is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Lipocine i.e., Lipocine and Summit Therapeutics go up and down completely randomly.

Pair Corralation between Lipocine and Summit Therapeutics

Given the investment horizon of 90 days Lipocine is expected to generate 1.04 times more return on investment than Summit Therapeutics. However, Lipocine is 1.04 times more volatile than Summit Therapeutics PLC. It trades about 0.04 of its potential returns per unit of risk. Summit Therapeutics PLC is currently generating about -0.04 per unit of risk. If you would invest  449.00  in Lipocine on September 28, 2024 and sell it today you would earn a total of  27.00  from holding Lipocine or generate 6.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lipocine  vs.  Summit Therapeutics PLC

Lipocine

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

Summit Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Summit Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's primary indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Lipocine and Summit Therapeutics

The main advantage of trading using opposite Lipocine and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.

The idea behind Lipocine and Summit Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.